title: More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia.
authors.forename: A
authors.initials: A
authors.lastname: Bertolotto
authors.forename: S
authors.initials: S
authors.lastname: Bandinelli
authors.forename: L
authors.initials: L
authors.lastname: Ruocco
authors.forename: A
authors.initials: A
authors.lastname: Lo Faro
authors.forename: G
authors.initials: G
authors.lastname: Penno
authors.forename: R
authors.initials: R
authors.lastname: Navalesi
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D000069059:Atorvastatin; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005340:Fibrinogen / Q000032:analysis / Q000187:drug effects*; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D011758:Pyrroles; D005340:Fibrinogen; D000069059:Atorvastatin